The field of cancer genomics and transcriptomics has evolved from targeted profiling to swift
sequencing of individual tumor genome and transcriptome. The steady growth in genome …

Cancer has been constantly evolving and so is the research pertaining to cancer diagnosis
and therapeutic regimens. Early detection and specific therapeutics are the key features of …

During the past century, our understanding of cancer diagnosis and treatment has been
based on a monogenic approach, and as a consequence our knowledge of the clinical …

Cancer is the leading cause of mortality among men and women worldwide. Despite the
availability of numerous diagnostic techniques for various cancers, the overall survival rate …

Cancer is a major disease and a heavy burden to public health. With the rapid development
of high-throughput (HTP) technologies, increasing multi-omics data have been produced to …

The acquisition of cancer hallmarks requires molecular alterations at multiple levels
including genome, epigenome, transcriptome, proteome, and metabolome. In the past …

Cancer is a multifaceted and complex disease that results from the disruption of genetic,
epigenetic, and metabolic systems responsible for maintaining physiological conditions in …

Background In the past decades, cancer enigmatical heterogeneity at distinct expression
levels could interpret disparities in therapeutic response and prognosis. It built hindrances to …

Cancer is a complex disease that involves multiple layers of genetic, epigenetic, and
metabolic alterations and interactions to orchestrate tumor growth and progression …

In this new era of cancer genomics, large-scale queries of whole genomic characteristics are
now possible not only for research and biological understanding, but also for molecular …